Diet and exercise during chemo for triple negative breast cancer
Part of Cancer, Skin clinical trials.
This study looks at whether a program of healthy eating and exercise, started during chemotherapy, can help shrink your tumor more effectively. You will be randomly assigned to either follow the diet and exercise plan or stick with your usual care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and are a woman.
- You have stage II or III triple negative breast cancer.
- You are about to start chemo-immunotherapy before your surgery.
- You are able to walk on your own.
- You are not currently exercising much (less than 150 minutes per week) and eat fewer than 7 servings of fruits and vegetables a day.
- You can read and understand English and get your oncologist's OK to join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an exercise program can help women with triple-negative breast cancer during their chemotherapy treatment. You will be asked to participate in a supervised exercise routine while receiving your standard cancer drugs.
This trial tests a combination of an immunotherapy drug (pembrolizumab) plus two chemotherapy drugs (carboplatin and paclitaxel) given before surgery for people with early-stage, triple-negative breast cancer. The goal is to see if this treatment helps shrink or eliminate the tumor before it's removed.
This trial tests a new combination of chemotherapy and immunotherapy that avoids a class of drugs called anthracyclines, which can be hard on the heart. The goal is to shrink tumors before surgery for people with triple-negative or low-hormone-receptor breast cancer.
This trial tests whether giving pembrolizumab (an immunotherapy drug) together with chemotherapy before surgery can help treat early-stage triple-negative breast cancer. It aims to improve outcomes by shrinking the tumor before removal.
This trial looks at whether a structured physical exercise program during neoadjuvant chemotherapy can help women with triple-negative breast cancer. You may qualify if you are treated at the specific hospital in Madrid and your tumor matches the required type and size.
This trial tests whether a structured exercise program can help women with newly diagnosed triple-negative breast cancer who are getting a specific combination of immunotherapy and chemotherapy. The goal is to see if staying active during treatment improves outcomes and well-being.
Hear when a new Triple Negative Breast Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.